Membranoproliferative Glomerulonephritis following the Oxford AstraZeneca COVID-19 Vaccine.

Hassani, Kawtar; Errihani, Majdouline; Mahamoud, Mohamed Houssein; ElKabbaj, Driss

Hassani, Kawtar; Errihani, Majdouline; Mahamoud, Mohamed Houssein; ElKabbaj, Driss.

Hassani K; Department of Nephrology, Faculty of Medicine and Pharmacy, Military Hospital of Instruction Mohammed V, Mohamed V University in Rabat, Rabat, Morocco.
Errihani M; Department of Nephrology, Faculty of Medicine and Pharmacy, Military Hospital of Instruction Mohammed V, Mohamed V University in Rabat, Rabat, Morocco.
Mahamoud MH; Department of Nephrology, Faculty of Medicine and Pharmacy, Military Hospital of Instruction Mohammed V, Mohamed V University in Rabat, Rabat, Morocco.
ElKabbaj D; Department of Nephrology, Faculty of Medicine and Pharmacy, Military Hospital of Instruction Mohammed V, Mohamed V University in Rabat, Rabat, Morocco.

Saudi J Kidney Dis Transpl ; 32(6): 1831-1832, 2021.

Article in English | MEDLINE | ID: covidwho-1975057

Subject(s)

COVID-19; Glomerulonephritis, Membranoproliferative; COVID-19/prevention & control; ChAdOx1 nCoV-19; Complement C3 Nephritic Factor; Glomerulonephritis, Membranoproliferative/diagnosis; Humans; Kidney Glomerulus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Glomerulonephritis, Membranoproliferative / COVID-19 Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Saudi J Kidney Dis Transpl Year: 2021 Document Type: Article Affiliation country: 1319-2442.352451

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google